Trial
NCT01808261
Proof of Concept (POC) in Patients With Ischaemic Stroke
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
GlaxoSmithKline
Collaborators
—
Condition
Cerebrovascular Accident
Intervention
GSK249320 100/mg
Why stopped
This study was terminated for futility.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-11-17